NCT03795506View on ClinicalTrials.gov

TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

NARecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

May 31, 2025

Conditions
Atopic Dermatitis Eczema
Interventions
DEVICE

Nocturnal Temperature controlled Laminar Airflow (TLA) Treatment

12 weeks of overnight treatment with active TLA device

DEVICE

Placebo TLA Device

12 weeks of overnight use of placebo TLA device

Trial Locations (1)

W2 1NY

RECRUITING

IMPERIAL COLLEGE HEALTHCARE NHS Trust, London

All Listed Sponsors
collaborator

JP Moulton Charitable Foundation

OTHER

lead

Imperial College London

OTHER

NCT03795506 - TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE) | Biotech Hunter | Biotech Hunter